DIN 02454343 — PRAXBIND 50 MG
PRAXBIND is a solution of Idarucizumab marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Idarucizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02454343
- Brand name
- PRAXBIND
- Active ingredient
- Idarucizumab
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- Monoclonal antibody fragment (dabigatran-specific reversal agent / antidote)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.